nodes	percent_of_prediction	percent_of_DWPC	metapath
Mefenamic acid—Niflumic Acid—Leflunomide—systemic lupus erythematosus	0.42	1	CrCrCtD
Mefenamic acid—PTGS2—systemic lupus erythematosus	0.161	1	CbGaD
Mefenamic acid—PTGS2—Dapsone—systemic lupus erythematosus	0.0394	0.146	CbGbCtD
Mefenamic acid—PTGS2—Triamcinolone—systemic lupus erythematosus	0.0342	0.126	CbGbCtD
Mefenamic acid—PTGS1—Dapsone—systemic lupus erythematosus	0.0333	0.123	CbGbCtD
Mefenamic acid—PTGS2—Betamethasone—systemic lupus erythematosus	0.0293	0.109	CbGbCtD
Mefenamic acid—CYP2C8—Dapsone—systemic lupus erythematosus	0.0192	0.0711	CbGbCtD
Mefenamic acid—CYP2C9—Leflunomide—systemic lupus erythematosus	0.0188	0.0696	CbGbCtD
Mefenamic acid—PTGS2—Dexamethasone—systemic lupus erythematosus	0.017	0.0631	CbGbCtD
Mefenamic acid—CYP2C8—Mycophenolate mofetil—systemic lupus erythematosus	0.0166	0.0616	CbGbCtD
Mefenamic acid—CYP2C9—Dapsone—systemic lupus erythematosus	0.0134	0.0496	CbGbCtD
Mefenamic acid—CYP2C8—Hydrocortisone—systemic lupus erythematosus	0.0134	0.0495	CbGbCtD
Mefenamic acid—CYP2C8—Cyclosporine—systemic lupus erythematosus	0.0126	0.0467	CbGbCtD
Mefenamic acid—CYP2C9—Cyclosporine—systemic lupus erythematosus	0.0088	0.0326	CbGbCtD
Mefenamic acid—CYP2C8—Dexamethasone—systemic lupus erythematosus	0.00831	0.0308	CbGbCtD
Mefenamic acid—CYP2C9—cardial valve—systemic lupus erythematosus	0.00599	0.318	CbGeAlD
Mefenamic acid—CYP2C9—Dexamethasone—systemic lupus erythematosus	0.00579	0.0215	CbGbCtD
Mefenamic acid—CYP2C9—urine—systemic lupus erythematosus	0.00129	0.0686	CbGeAlD
Mefenamic acid—AKR1C3—nephron tubule—systemic lupus erythematosus	0.000897	0.0477	CbGeAlD
Mefenamic acid—AKR1C3—cortex of kidney—systemic lupus erythematosus	0.000768	0.0408	CbGeAlD
Mefenamic acid—CYP2C8—blood plasma—systemic lupus erythematosus	0.000759	0.0403	CbGeAlD
Mefenamic acid—PTGS1—endothelium—systemic lupus erythematosus	0.000693	0.0368	CbGeAlD
Mefenamic acid—CYP2C9—blood plasma—systemic lupus erythematosus	0.000674	0.0358	CbGeAlD
Mefenamic acid—PTGS2—endothelium—systemic lupus erythematosus	0.000662	0.0352	CbGeAlD
Mefenamic acid—AKR1C3—tendon—systemic lupus erythematosus	0.000637	0.0338	CbGeAlD
Mefenamic acid—AKR1C3—bone marrow—systemic lupus erythematosus	0.000617	0.0328	CbGeAlD
Mefenamic acid—PTGS1—blood plasma—systemic lupus erythematosus	0.000615	0.0327	CbGeAlD
Mefenamic acid—PTGS2—blood plasma—systemic lupus erythematosus	0.000588	0.0312	CbGeAlD
Mefenamic acid—AKR1C3—lung—systemic lupus erythematosus	0.000559	0.0297	CbGeAlD
Mefenamic acid—CYP2C8—kidney—systemic lupus erythematosus	0.000344	0.0183	CbGeAlD
Mefenamic acid—PTGS1—connective tissue—systemic lupus erythematosus	0.000328	0.0174	CbGeAlD
Mefenamic acid—PTGS2—Fluocinonide—Methylprednisolone—systemic lupus erythematosus	0.000318	0.159	CbGdCrCtD
Mefenamic acid—PTGS2—connective tissue—systemic lupus erythematosus	0.000313	0.0166	CbGeAlD
Mefenamic acid—PTGS2—Fluocinonide—Dexamethasone—systemic lupus erythematosus	0.000313	0.156	CbGdCrCtD
Mefenamic acid—PTGS2—Fluocinonide—Betamethasone—systemic lupus erythematosus	0.000313	0.156	CbGdCrCtD
Mefenamic acid—Floctafenine—PTGS2—systemic lupus erythematosus	0.000308	0.123	CrCbGaD
Mefenamic acid—PTGS2—Fluocinonide—Triamcinolone—systemic lupus erythematosus	0.000306	0.153	CbGdCrCtD
Mefenamic acid—PTGS1—skin of body—systemic lupus erythematosus	0.000296	0.0157	CbGeAlD
Mefenamic acid—PTGS2—skin of body—systemic lupus erythematosus	0.000283	0.015	CbGeAlD
Mefenamic acid—PTGS1—kidney—systemic lupus erythematosus	0.000279	0.0148	CbGeAlD
Mefenamic acid—PTGS2—kidney—systemic lupus erythematosus	0.000267	0.0142	CbGeAlD
Mefenamic acid—PTGS2—lymphoid tissue—systemic lupus erythematosus	0.000229	0.0122	CbGeAlD
Mefenamic acid—PTGS1—tendon—systemic lupus erythematosus	0.000225	0.012	CbGeAlD
Mefenamic acid—PTGS2—tendon—systemic lupus erythematosus	0.000215	0.0114	CbGeAlD
Mefenamic acid—PTGS2—bone marrow—systemic lupus erythematosus	0.000209	0.0111	CbGeAlD
Mefenamic acid—Lumiracoxib—PTGS2—systemic lupus erythematosus	0.000198	0.0794	CrCbGaD
Mefenamic acid—Tiaprofenic acid—PTGS2—systemic lupus erythematosus	0.000198	0.0794	CrCbGaD
Mefenamic acid—PTGS1—lung—systemic lupus erythematosus	0.000198	0.0105	CbGeAlD
Mefenamic acid—PTGS2—Fluticasone Propionate—Methylprednisolone—systemic lupus erythematosus	0.000192	0.0957	CbGdCrCtD
Mefenamic acid—PTGS2—lung—systemic lupus erythematosus	0.000189	0.01	CbGeAlD
Mefenamic acid—PTGS2—Fluticasone Propionate—Dexamethasone—systemic lupus erythematosus	0.000189	0.0942	CbGdCrCtD
Mefenamic acid—PTGS2—Fluticasone Propionate—Betamethasone—systemic lupus erythematosus	0.000189	0.0942	CbGdCrCtD
Mefenamic acid—Nepafenac—PTGS2—systemic lupus erythematosus	0.000189	0.0755	CrCbGaD
Mefenamic acid—PTGS2—Fluticasone Propionate—Triamcinolone—systemic lupus erythematosus	0.000184	0.0921	CbGdCrCtD
Mefenamic acid—PTGS1—nervous system—systemic lupus erythematosus	0.000183	0.00972	CbGeAlD
Mefenamic acid—Niflumic Acid—PTGS2—systemic lupus erythematosus	0.000177	0.0708	CrCbGaD
Mefenamic acid—PTGS1—central nervous system—systemic lupus erythematosus	0.000176	0.00936	CbGeAlD
Mefenamic acid—PTGS2—nervous system—systemic lupus erythematosus	0.000175	0.00929	CbGeAlD
Mefenamic acid—PTGS2—central nervous system—systemic lupus erythematosus	0.000168	0.00895	CbGeAlD
Mefenamic acid—Salsalate—PTGS2—systemic lupus erythematosus	0.000157	0.0628	CrCbGaD
Mefenamic acid—Meclofenamic acid—PTGS2—systemic lupus erythematosus	0.000155	0.0619	CrCbGaD
Mefenamic acid—Fenoprofen—PTGS2—systemic lupus erythematosus	0.00013	0.0519	CrCbGaD
Mefenamic acid—Acetylsalicylic acid—PTGS2—systemic lupus erythematosus	0.000117	0.0469	CrCbGaD
Mefenamic acid—Fenoprofen—ALB—systemic lupus erythematosus	0.000115	0.0462	CrCbGaD
Mefenamic acid—Acetylsalicylic acid—ALB—systemic lupus erythematosus	0.000104	0.0418	CrCbGaD
Mefenamic acid—Salicylic acid—PTGS2—systemic lupus erythematosus	9.64e-05	0.0386	CrCbGaD
Mefenamic acid—Diclofenac—PTGS2—systemic lupus erythematosus	8.63e-05	0.0346	CrCbGaD
Mefenamic acid—Salicylic acid—ALB—systemic lupus erythematosus	8.59e-05	0.0344	CrCbGaD
Mefenamic acid—Flurbiprofen—PTGS2—systemic lupus erythematosus	8.45e-05	0.0338	CrCbGaD
Mefenamic acid—Diclofenac—ALB—systemic lupus erythematosus	7.69e-05	0.0308	CrCbGaD
Mefenamic acid—Ketoprofen—PTGS2—systemic lupus erythematosus	7.65e-05	0.0306	CrCbGaD
Mefenamic acid—Flurbiprofen—ALB—systemic lupus erythematosus	7.53e-05	0.0302	CrCbGaD
Mefenamic acid—Ketoprofen—ALB—systemic lupus erythematosus	6.81e-05	0.0273	CrCbGaD
Mefenamic acid—Vomiting—Leflunomide—systemic lupus erythematosus	6.66e-05	0.000655	CcSEcCtD
Mefenamic acid—Shock—Triamcinolone—systemic lupus erythematosus	6.66e-05	0.000655	CcSEcCtD
Mefenamic acid—Insomnia—Prednisolone—systemic lupus erythematosus	6.66e-05	0.000654	CcSEcCtD
Mefenamic acid—Alopecia—Prednisone—systemic lupus erythematosus	6.65e-05	0.000654	CcSEcCtD
Mefenamic acid—Shock—Methylprednisolone—systemic lupus erythematosus	6.64e-05	0.000653	CcSEcCtD
Mefenamic acid—Gastrointestinal pain—Cyclosporine—systemic lupus erythematosus	6.61e-05	0.00065	CcSEcCtD
Mefenamic acid—Loss of consciousness—Betamethasone—systemic lupus erythematosus	6.61e-05	0.00065	CcSEcCtD
Mefenamic acid—Loss of consciousness—Dexamethasone—systemic lupus erythematosus	6.61e-05	0.00065	CcSEcCtD
Mefenamic acid—Paraesthesia—Prednisolone—systemic lupus erythematosus	6.61e-05	0.00065	CcSEcCtD
Mefenamic acid—Rash—Leflunomide—systemic lupus erythematosus	6.61e-05	0.000649	CcSEcCtD
Mefenamic acid—Tachycardia—Triamcinolone—systemic lupus erythematosus	6.6e-05	0.000649	CcSEcCtD
Mefenamic acid—Dermatitis—Leflunomide—systemic lupus erythematosus	6.6e-05	0.000649	CcSEcCtD
Mefenamic acid—Mental disorder—Prednisone—systemic lupus erythematosus	6.59e-05	0.000648	CcSEcCtD
Mefenamic acid—Nausea—Azathioprine—systemic lupus erythematosus	6.59e-05	0.000648	CcSEcCtD
Mefenamic acid—Tachycardia—Methylprednisolone—systemic lupus erythematosus	6.59e-05	0.000648	CcSEcCtD
Mefenamic acid—Headache—Leflunomide—systemic lupus erythematosus	6.56e-05	0.000645	CcSEcCtD
Mefenamic acid—Skin disorder—Methylprednisolone—systemic lupus erythematosus	6.56e-05	0.000645	CcSEcCtD
Mefenamic acid—Agranulocytosis—Methotrexate—systemic lupus erythematosus	6.54e-05	0.000643	CcSEcCtD
Mefenamic acid—Convulsion—Dexamethasone—systemic lupus erythematosus	6.52e-05	0.000641	CcSEcCtD
Mefenamic acid—Convulsion—Betamethasone—systemic lupus erythematosus	6.52e-05	0.000641	CcSEcCtD
Mefenamic acid—Feeling abnormal—Mycophenolate mofetil—systemic lupus erythematosus	6.5e-05	0.000639	CcSEcCtD
Mefenamic acid—Insomnia—Hydrocortisone—systemic lupus erythematosus	6.5e-05	0.000639	CcSEcCtD
Mefenamic acid—Hypertension—Betamethasone—systemic lupus erythematosus	6.5e-05	0.000639	CcSEcCtD
Mefenamic acid—Hypertension—Dexamethasone—systemic lupus erythematosus	6.5e-05	0.000639	CcSEcCtD
Mefenamic acid—Paraesthesia—Hydrocortisone—systemic lupus erythematosus	6.45e-05	0.000634	CcSEcCtD
Mefenamic acid—Gastrointestinal pain—Mycophenolate mofetil—systemic lupus erythematosus	6.45e-05	0.000634	CcSEcCtD
Mefenamic acid—Urticaria—Cyclosporine—systemic lupus erythematosus	6.42e-05	0.000632	CcSEcCtD
Mefenamic acid—Abdominal pain—Cyclosporine—systemic lupus erythematosus	6.39e-05	0.000628	CcSEcCtD
Mefenamic acid—Body temperature increased—Cyclosporine—systemic lupus erythematosus	6.39e-05	0.000628	CcSEcCtD
Mefenamic acid—Anxiety—Dexamethasone—systemic lupus erythematosus	6.38e-05	0.000628	CcSEcCtD
Mefenamic acid—Anxiety—Betamethasone—systemic lupus erythematosus	6.38e-05	0.000628	CcSEcCtD
Mefenamic acid—Discomfort—Betamethasone—systemic lupus erythematosus	6.33e-05	0.000622	CcSEcCtD
Mefenamic acid—Discomfort—Dexamethasone—systemic lupus erythematosus	6.33e-05	0.000622	CcSEcCtD
Mefenamic acid—Dyspepsia—Hydrocortisone—systemic lupus erythematosus	6.33e-05	0.000622	CcSEcCtD
Mefenamic acid—Haemoglobin—Methotrexate—systemic lupus erythematosus	6.32e-05	0.000622	CcSEcCtD
Mefenamic acid—Hypotension—Methylprednisolone—systemic lupus erythematosus	6.31e-05	0.00062	CcSEcCtD
Mefenamic acid—Hepatitis—Methotrexate—systemic lupus erythematosus	6.29e-05	0.000618	CcSEcCtD
Mefenamic acid—Haemorrhage—Methotrexate—systemic lupus erythematosus	6.29e-05	0.000618	CcSEcCtD
Mefenamic acid—Urticaria—Mycophenolate mofetil—systemic lupus erythematosus	6.27e-05	0.000616	CcSEcCtD
Mefenamic acid—Decreased appetite—Hydrocortisone—systemic lupus erythematosus	6.25e-05	0.000614	CcSEcCtD
Mefenamic acid—Abdominal pain—Mycophenolate mofetil—systemic lupus erythematosus	6.24e-05	0.000613	CcSEcCtD
Mefenamic acid—Body temperature increased—Mycophenolate mofetil—systemic lupus erythematosus	6.24e-05	0.000613	CcSEcCtD
Mefenamic acid—Nausea—Leflunomide—systemic lupus erythematosus	6.22e-05	0.000612	CcSEcCtD
Mefenamic acid—Urinary tract disorder—Methotrexate—systemic lupus erythematosus	6.21e-05	0.000611	CcSEcCtD
Mefenamic acid—Gastrointestinal disorder—Hydrocortisone—systemic lupus erythematosus	6.2e-05	0.00061	CcSEcCtD
Mefenamic acid—Vision blurred—Prednisone—systemic lupus erythematosus	6.17e-05	0.000607	CcSEcCtD
Mefenamic acid—Urethral disorder—Methotrexate—systemic lupus erythematosus	6.17e-05	0.000606	CcSEcCtD
Mefenamic acid—Anaphylactic shock—Dexamethasone—systemic lupus erythematosus	6.14e-05	0.000604	CcSEcCtD
Mefenamic acid—Anaphylactic shock—Betamethasone—systemic lupus erythematosus	6.14e-05	0.000604	CcSEcCtD
Mefenamic acid—Oedema—Betamethasone—systemic lupus erythematosus	6.14e-05	0.000604	CcSEcCtD
Mefenamic acid—Oedema—Dexamethasone—systemic lupus erythematosus	6.14e-05	0.000604	CcSEcCtD
Mefenamic acid—Insomnia—Triamcinolone—systemic lupus erythematosus	6.12e-05	0.000602	CcSEcCtD
Mefenamic acid—Insomnia—Methylprednisolone—systemic lupus erythematosus	6.11e-05	0.0006	CcSEcCtD
Mefenamic acid—Infection—Dexamethasone—systemic lupus erythematosus	6.1e-05	0.0006	CcSEcCtD
Mefenamic acid—Infection—Betamethasone—systemic lupus erythematosus	6.1e-05	0.0006	CcSEcCtD
Mefenamic acid—Ill-defined disorder—Prednisone—systemic lupus erythematosus	6.08e-05	0.000598	CcSEcCtD
Mefenamic acid—Paraesthesia—Triamcinolone—systemic lupus erythematosus	6.08e-05	0.000597	CcSEcCtD
Mefenamic acid—Feeling abnormal—Prednisolone—systemic lupus erythematosus	6.06e-05	0.000596	CcSEcCtD
Mefenamic acid—Paraesthesia—Methylprednisolone—systemic lupus erythematosus	6.06e-05	0.000596	CcSEcCtD
Mefenamic acid—Anaemia—Prednisone—systemic lupus erythematosus	6.06e-05	0.000595	CcSEcCtD
Mefenamic acid—Shock—Betamethasone—systemic lupus erythematosus	6.04e-05	0.000594	CcSEcCtD
Mefenamic acid—Shock—Dexamethasone—systemic lupus erythematosus	6.04e-05	0.000594	CcSEcCtD
Mefenamic acid—Dyspnoea—Triamcinolone—systemic lupus erythematosus	6.03e-05	0.000593	CcSEcCtD
Mefenamic acid—Thrombocytopenia—Dexamethasone—systemic lupus erythematosus	6.01e-05	0.000591	CcSEcCtD
Mefenamic acid—Thrombocytopenia—Betamethasone—systemic lupus erythematosus	6.01e-05	0.000591	CcSEcCtD
Mefenamic acid—Tachycardia—Betamethasone—systemic lupus erythematosus	5.99e-05	0.000589	CcSEcCtD
Mefenamic acid—Tachycardia—Dexamethasone—systemic lupus erythematosus	5.99e-05	0.000589	CcSEcCtD
Mefenamic acid—Angioedema—Prednisone—systemic lupus erythematosus	5.99e-05	0.000589	CcSEcCtD
Mefenamic acid—Dyspepsia—Triamcinolone—systemic lupus erythematosus	5.96e-05	0.000586	CcSEcCtD
Mefenamic acid—Erythema multiforme—Methotrexate—systemic lupus erythematosus	5.95e-05	0.000585	CcSEcCtD
Mefenamic acid—Dyspepsia—Methylprednisolone—systemic lupus erythematosus	5.94e-05	0.000584	CcSEcCtD
Mefenamic acid—Feeling abnormal—Hydrocortisone—systemic lupus erythematosus	5.92e-05	0.000582	CcSEcCtD
Mefenamic acid—Malaise—Prednisone—systemic lupus erythematosus	5.91e-05	0.000581	CcSEcCtD
Mefenamic acid—Vertigo—Prednisone—systemic lupus erythematosus	5.89e-05	0.000579	CcSEcCtD
Mefenamic acid—Gastrointestinal pain—Hydrocortisone—systemic lupus erythematosus	5.88e-05	0.000578	CcSEcCtD
Mefenamic acid—Syncope—Prednisone—systemic lupus erythematosus	5.88e-05	0.000578	CcSEcCtD
Mefenamic acid—Tinnitus—Methotrexate—systemic lupus erythematosus	5.86e-05	0.000577	CcSEcCtD
Mefenamic acid—Anorexia—Dexamethasone—systemic lupus erythematosus	5.85e-05	0.000575	CcSEcCtD
Mefenamic acid—Anorexia—Betamethasone—systemic lupus erythematosus	5.85e-05	0.000575	CcSEcCtD
Mefenamic acid—Urticaria—Prednisolone—systemic lupus erythematosus	5.85e-05	0.000575	CcSEcCtD
Mefenamic acid—Asthenia—Cyclosporine—systemic lupus erythematosus	5.8e-05	0.00057	CcSEcCtD
Mefenamic acid—Loss of consciousness—Prednisone—systemic lupus erythematosus	5.76e-05	0.000566	CcSEcCtD
Mefenamic acid—Hypotension—Betamethasone—systemic lupus erythematosus	5.74e-05	0.000564	CcSEcCtD
Mefenamic acid—Hypotension—Dexamethasone—systemic lupus erythematosus	5.74e-05	0.000564	CcSEcCtD
Mefenamic acid—Pruritus—Cyclosporine—systemic lupus erythematosus	5.72e-05	0.000562	CcSEcCtD
Mefenamic acid—Urticaria—Hydrocortisone—systemic lupus erythematosus	5.71e-05	0.000561	CcSEcCtD
Mefenamic acid—CYP2C9—Cytochrome P450 - arranged by substrate type—RXRA—systemic lupus erythematosus	5.71e-05	0.00241	CbGpPWpGaD
Mefenamic acid—CYP2C8—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	5.68e-05	0.0024	CbGpPWpGaD
Mefenamic acid—Abdominal pain—Hydrocortisone—systemic lupus erythematosus	5.68e-05	0.000559	CcSEcCtD
Mefenamic acid—Body temperature increased—Hydrocortisone—systemic lupus erythematosus	5.68e-05	0.000559	CcSEcCtD
Mefenamic acid—Convulsion—Prednisone—systemic lupus erythematosus	5.68e-05	0.000558	CcSEcCtD
Mefenamic acid—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—systemic lupus erythematosus	5.67e-05	0.00239	CbGpPWpGaD
Mefenamic acid—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	5.66e-05	0.000556	CcSEcCtD
Mefenamic acid—Hypertension—Prednisone—systemic lupus erythematosus	5.66e-05	0.000556	CcSEcCtD
Mefenamic acid—Pruritus—Mycophenolate mofetil—systemic lupus erythematosus	5.58e-05	0.000549	CcSEcCtD
Mefenamic acid—Feeling abnormal—Triamcinolone—systemic lupus erythematosus	5.58e-05	0.000548	CcSEcCtD
Mefenamic acid—Feeling abnormal—Methylprednisolone—systemic lupus erythematosus	5.56e-05	0.000547	CcSEcCtD
Mefenamic acid—Anxiety—Prednisone—systemic lupus erythematosus	5.56e-05	0.000546	CcSEcCtD
Mefenamic acid—Alopecia—Methotrexate—systemic lupus erythematosus	5.56e-05	0.000546	CcSEcCtD
Mefenamic acid—Insomnia—Betamethasone—systemic lupus erythematosus	5.55e-05	0.000546	CcSEcCtD
Mefenamic acid—Insomnia—Dexamethasone—systemic lupus erythematosus	5.55e-05	0.000546	CcSEcCtD
Mefenamic acid—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic lupus erythematosus	5.54e-05	0.000545	CcSEcCtD
Mefenamic acid—Diarrhoea—Cyclosporine—systemic lupus erythematosus	5.53e-05	0.000544	CcSEcCtD
Mefenamic acid—Gastrointestinal pain—Methylprednisolone—systemic lupus erythematosus	5.52e-05	0.000543	CcSEcCtD
Mefenamic acid—Paraesthesia—Dexamethasone—systemic lupus erythematosus	5.51e-05	0.000542	CcSEcCtD
Mefenamic acid—Paraesthesia—Betamethasone—systemic lupus erythematosus	5.51e-05	0.000542	CcSEcCtD
Mefenamic acid—Discomfort—Prednisone—systemic lupus erythematosus	5.51e-05	0.000542	CcSEcCtD
Mefenamic acid—Mental disorder—Methotrexate—systemic lupus erythematosus	5.51e-05	0.000542	CcSEcCtD
Mefenamic acid—PTGS1—Selenium Micronutrient Network—F2—systemic lupus erythematosus	5.46e-05	0.0023	CbGpPWpGaD
Mefenamic acid—Dyspepsia—Dexamethasone—systemic lupus erythematosus	5.4e-05	0.000531	CcSEcCtD
Mefenamic acid—Dyspepsia—Betamethasone—systemic lupus erythematosus	5.4e-05	0.000531	CcSEcCtD
Mefenamic acid—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	5.4e-05	0.000531	CcSEcCtD
Mefenamic acid—CYP2C8—Biological oxidations—NAT2—systemic lupus erythematosus	5.39e-05	0.00227	CbGpPWpGaD
Mefenamic acid—Urticaria—Triamcinolone—systemic lupus erythematosus	5.38e-05	0.000528	CcSEcCtD
Mefenamic acid—Urticaria—Methylprednisolone—systemic lupus erythematosus	5.36e-05	0.000527	CcSEcCtD
Mefenamic acid—Body temperature increased—Triamcinolone—systemic lupus erythematosus	5.35e-05	0.000526	CcSEcCtD
Mefenamic acid—Dizziness—Cyclosporine—systemic lupus erythematosus	5.35e-05	0.000526	CcSEcCtD
Mefenamic acid—Oedema—Prednisone—systemic lupus erythematosus	5.35e-05	0.000526	CcSEcCtD
Mefenamic acid—Anaphylactic shock—Prednisone—systemic lupus erythematosus	5.35e-05	0.000526	CcSEcCtD
Mefenamic acid—Abdominal pain—Methylprednisolone—systemic lupus erythematosus	5.34e-05	0.000525	CcSEcCtD
Mefenamic acid—Decreased appetite—Betamethasone—systemic lupus erythematosus	5.34e-05	0.000525	CcSEcCtD
Mefenamic acid—Decreased appetite—Dexamethasone—systemic lupus erythematosus	5.34e-05	0.000525	CcSEcCtD
Mefenamic acid—AKR1C1—Disease—HIST2H2AC—systemic lupus erythematosus	5.32e-05	0.00224	CbGpPWpGaD
Mefenamic acid—Infection—Prednisone—systemic lupus erythematosus	5.31e-05	0.000522	CcSEcCtD
Mefenamic acid—CYP2C8—Metapathway biotransformation—NAT2—systemic lupus erythematosus	5.31e-05	0.00224	CbGpPWpGaD
Mefenamic acid—Gastrointestinal disorder—Betamethasone—systemic lupus erythematosus	5.3e-05	0.000521	CcSEcCtD
Mefenamic acid—Gastrointestinal disorder—Dexamethasone—systemic lupus erythematosus	5.3e-05	0.000521	CcSEcCtD
Mefenamic acid—AKR1C2—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	5.27e-05	0.00222	CbGpPWpGaD
Mefenamic acid—Shock—Prednisone—systemic lupus erythematosus	5.26e-05	0.000517	CcSEcCtD
Mefenamic acid—Tachycardia—Prednisone—systemic lupus erythematosus	5.22e-05	0.000513	CcSEcCtD
Mefenamic acid—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	5.22e-05	0.000513	CcSEcCtD
Mefenamic acid—Skin disorder—Prednisone—systemic lupus erythematosus	5.19e-05	0.000511	CcSEcCtD
Mefenamic acid—AKR1C1—Disease—CSK—systemic lupus erythematosus	5.18e-05	0.00219	CbGpPWpGaD
Mefenamic acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—systemic lupus erythematosus	5.16e-05	0.00218	CbGpPWpGaD
Mefenamic acid—Vision blurred—Methotrexate—systemic lupus erythematosus	5.16e-05	0.000507	CcSEcCtD
Mefenamic acid—Asthenia—Hydrocortisone—systemic lupus erythematosus	5.16e-05	0.000507	CcSEcCtD
Mefenamic acid—Vomiting—Cyclosporine—systemic lupus erythematosus	5.14e-05	0.000505	CcSEcCtD
Mefenamic acid—Rash—Cyclosporine—systemic lupus erythematosus	5.1e-05	0.000501	CcSEcCtD
Mefenamic acid—Anorexia—Prednisone—systemic lupus erythematosus	5.1e-05	0.000501	CcSEcCtD
Mefenamic acid—Dermatitis—Cyclosporine—systemic lupus erythematosus	5.09e-05	0.000501	CcSEcCtD
Mefenamic acid—Pruritus—Hydrocortisone—systemic lupus erythematosus	5.08e-05	0.0005	CcSEcCtD
Mefenamic acid—Ill-defined disorder—Methotrexate—systemic lupus erythematosus	5.08e-05	0.000499	CcSEcCtD
Mefenamic acid—Headache—Cyclosporine—systemic lupus erythematosus	5.07e-05	0.000498	CcSEcCtD
Mefenamic acid—Anaemia—Methotrexate—systemic lupus erythematosus	5.06e-05	0.000498	CcSEcCtD
Mefenamic acid—Feeling abnormal—Betamethasone—systemic lupus erythematosus	5.06e-05	0.000497	CcSEcCtD
Mefenamic acid—Feeling abnormal—Dexamethasone—systemic lupus erythematosus	5.06e-05	0.000497	CcSEcCtD
Mefenamic acid—Gastrointestinal pain—Betamethasone—systemic lupus erythematosus	5.02e-05	0.000494	CcSEcCtD
Mefenamic acid—Gastrointestinal pain—Dexamethasone—systemic lupus erythematosus	5.02e-05	0.000494	CcSEcCtD
Mefenamic acid—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	5.02e-05	0.000493	CcSEcCtD
Mefenamic acid—PTGS2—Aryl Hydrocarbon Receptor—CDKN1B—systemic lupus erythematosus	5.01e-05	0.00212	CbGpPWpGaD
Mefenamic acid—Rash—Mycophenolate mofetil—systemic lupus erythematosus	4.97e-05	0.000489	CcSEcCtD
Mefenamic acid—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	4.97e-05	0.000489	CcSEcCtD
Mefenamic acid—Headache—Mycophenolate mofetil—systemic lupus erythematosus	4.94e-05	0.000486	CcSEcCtD
Mefenamic acid—Malaise—Methotrexate—systemic lupus erythematosus	4.94e-05	0.000485	CcSEcCtD
Mefenamic acid—Vertigo—Methotrexate—systemic lupus erythematosus	4.92e-05	0.000484	CcSEcCtD
Mefenamic acid—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	4.92e-05	0.000483	CcSEcCtD
Mefenamic acid—Leukopenia—Methotrexate—systemic lupus erythematosus	4.9e-05	0.000482	CcSEcCtD
Mefenamic acid—Urticaria—Betamethasone—systemic lupus erythematosus	4.88e-05	0.00048	CcSEcCtD
Mefenamic acid—Urticaria—Dexamethasone—systemic lupus erythematosus	4.88e-05	0.00048	CcSEcCtD
Mefenamic acid—AKR1C1—Disease—CD247—systemic lupus erythematosus	4.87e-05	0.00206	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism—NAT2—systemic lupus erythematosus	4.87e-05	0.00205	CbGpPWpGaD
Mefenamic acid—PTGS1—Selenium Micronutrient Network—CCL2—systemic lupus erythematosus	4.87e-05	0.00205	CbGpPWpGaD
Mefenamic acid—Dizziness—Prednisolone—systemic lupus erythematosus	4.87e-05	0.000478	CcSEcCtD
Mefenamic acid—Asthenia—Triamcinolone—systemic lupus erythematosus	4.86e-05	0.000477	CcSEcCtD
Mefenamic acid—Abdominal pain—Dexamethasone—systemic lupus erythematosus	4.85e-05	0.000477	CcSEcCtD
Mefenamic acid—Abdominal pain—Betamethasone—systemic lupus erythematosus	4.85e-05	0.000477	CcSEcCtD
Mefenamic acid—Body temperature increased—Dexamethasone—systemic lupus erythematosus	4.85e-05	0.000477	CcSEcCtD
Mefenamic acid—Body temperature increased—Betamethasone—systemic lupus erythematosus	4.85e-05	0.000477	CcSEcCtD
Mefenamic acid—AKR1C3—Disease—XRCC6—systemic lupus erythematosus	4.85e-05	0.00205	CbGpPWpGaD
Mefenamic acid—Asthenia—Methylprednisolone—systemic lupus erythematosus	4.84e-05	0.000476	CcSEcCtD
Mefenamic acid—Insomnia—Prednisone—systemic lupus erythematosus	4.84e-05	0.000475	CcSEcCtD
Mefenamic acid—Nausea—Cyclosporine—systemic lupus erythematosus	4.8e-05	0.000472	CcSEcCtD
Mefenamic acid—Paraesthesia—Prednisone—systemic lupus erythematosus	4.8e-05	0.000472	CcSEcCtD
Mefenamic acid—Pruritus—Triamcinolone—systemic lupus erythematosus	4.79e-05	0.000471	CcSEcCtD
Mefenamic acid—Pruritus—Methylprednisolone—systemic lupus erythematosus	4.78e-05	0.00047	CcSEcCtD
Mefenamic acid—Dizziness—Hydrocortisone—systemic lupus erythematosus	4.75e-05	0.000467	CcSEcCtD
Mefenamic acid—Convulsion—Methotrexate—systemic lupus erythematosus	4.74e-05	0.000466	CcSEcCtD
Mefenamic acid—AKR1C2—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	4.74e-05	0.002	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—NCF2—systemic lupus erythematosus	4.74e-05	0.002	CbGpPWpGaD
Mefenamic acid—Dyspepsia—Prednisone—systemic lupus erythematosus	4.71e-05	0.000463	CcSEcCtD
Mefenamic acid—PTGS2—Selenium Micronutrient Network—CRP—systemic lupus erythematosus	4.7e-05	0.00198	CbGpPWpGaD
Mefenamic acid—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	4.69e-05	0.000461	CcSEcCtD
Mefenamic acid—PTGS1—Biological oxidations—RXRA—systemic lupus erythematosus	4.67e-05	0.00197	CbGpPWpGaD
Mefenamic acid—Decreased appetite—Prednisone—systemic lupus erythematosus	4.65e-05	0.000457	CcSEcCtD
Mefenamic acid—Rash—Prednisolone—systemic lupus erythematosus	4.64e-05	0.000456	CcSEcCtD
Mefenamic acid—Dermatitis—Prednisolone—systemic lupus erythematosus	4.64e-05	0.000456	CcSEcCtD
Mefenamic acid—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic lupus erythematosus	4.63e-05	0.000455	CcSEcCtD
Mefenamic acid—PTGS2—Aryl Hydrocarbon Receptor—CDKN1A—systemic lupus erythematosus	4.63e-05	0.00195	CbGpPWpGaD
Mefenamic acid—CYP2C9—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	4.63e-05	0.00195	CbGpPWpGaD
Mefenamic acid—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	4.62e-05	0.000454	CcSEcCtD
Mefenamic acid—Headache—Prednisolone—systemic lupus erythematosus	4.61e-05	0.000453	CcSEcCtD
Mefenamic acid—Discomfort—Methotrexate—systemic lupus erythematosus	4.61e-05	0.000453	CcSEcCtD
Mefenamic acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—systemic lupus erythematosus	4.59e-05	0.00194	CbGpPWpGaD
Mefenamic acid—Constipation—Prednisone—systemic lupus erythematosus	4.57e-05	0.00045	CcSEcCtD
Mefenamic acid—Vomiting—Hydrocortisone—systemic lupus erythematosus	4.57e-05	0.000449	CcSEcCtD
Mefenamic acid—PTGS1—Selenium Micronutrient Network—ALB—systemic lupus erythematosus	4.54e-05	0.00191	CbGpPWpGaD
Mefenamic acid—Rash—Hydrocortisone—systemic lupus erythematosus	4.53e-05	0.000445	CcSEcCtD
Mefenamic acid—Dermatitis—Hydrocortisone—systemic lupus erythematosus	4.53e-05	0.000445	CcSEcCtD
Mefenamic acid—Confusional state—Methotrexate—systemic lupus erythematosus	4.51e-05	0.000443	CcSEcCtD
Mefenamic acid—Headache—Hydrocortisone—systemic lupus erythematosus	4.5e-05	0.000443	CcSEcCtD
Mefenamic acid—Dizziness—Triamcinolone—systemic lupus erythematosus	4.47e-05	0.00044	CcSEcCtD
Mefenamic acid—Anaphylactic shock—Methotrexate—systemic lupus erythematosus	4.47e-05	0.000439	CcSEcCtD
Mefenamic acid—Dizziness—Methylprednisolone—systemic lupus erythematosus	4.46e-05	0.000439	CcSEcCtD
Mefenamic acid—Infection—Methotrexate—systemic lupus erythematosus	4.44e-05	0.000436	CcSEcCtD
Mefenamic acid—Feeling abnormal—Prednisone—systemic lupus erythematosus	4.41e-05	0.000433	CcSEcCtD
Mefenamic acid—Asthenia—Dexamethasone—systemic lupus erythematosus	4.41e-05	0.000433	CcSEcCtD
Mefenamic acid—Asthenia—Betamethasone—systemic lupus erythematosus	4.41e-05	0.000433	CcSEcCtD
Mefenamic acid—PTGS2—Aryl Hydrocarbon Receptor—EP300—systemic lupus erythematosus	4.4e-05	0.00186	CbGpPWpGaD
Mefenamic acid—CYP2C9—Biological oxidations—NAT2—systemic lupus erythematosus	4.38e-05	0.00185	CbGpPWpGaD
Mefenamic acid—Thrombocytopenia—Methotrexate—systemic lupus erythematosus	4.38e-05	0.00043	CcSEcCtD
Mefenamic acid—Gastrointestinal pain—Prednisone—systemic lupus erythematosus	4.37e-05	0.00043	CcSEcCtD
Mefenamic acid—Nausea—Prednisolone—systemic lupus erythematosus	4.37e-05	0.00043	CcSEcCtD
Mefenamic acid—Pruritus—Betamethasone—systemic lupus erythematosus	4.34e-05	0.000427	CcSEcCtD
Mefenamic acid—Pruritus—Dexamethasone—systemic lupus erythematosus	4.34e-05	0.000427	CcSEcCtD
Mefenamic acid—Skin disorder—Methotrexate—systemic lupus erythematosus	4.34e-05	0.000427	CcSEcCtD
Mefenamic acid—PTGS2—Selenium Micronutrient Network—F2—systemic lupus erythematosus	4.34e-05	0.00183	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metapathway biotransformation—NAT2—systemic lupus erythematosus	4.32e-05	0.00182	CbGpPWpGaD
Mefenamic acid—Vomiting—Triamcinolone—systemic lupus erythematosus	4.3e-05	0.000423	CcSEcCtD
Mefenamic acid—PTGS2—Spinal Cord Injury—IL4—systemic lupus erythematosus	4.3e-05	0.00181	CbGpPWpGaD
Mefenamic acid—Vomiting—Methylprednisolone—systemic lupus erythematosus	4.29e-05	0.000422	CcSEcCtD
Mefenamic acid—Nausea—Hydrocortisone—systemic lupus erythematosus	4.27e-05	0.00042	CcSEcCtD
Mefenamic acid—Rash—Triamcinolone—systemic lupus erythematosus	4.27e-05	0.000419	CcSEcCtD
Mefenamic acid—Dermatitis—Triamcinolone—systemic lupus erythematosus	4.26e-05	0.000419	CcSEcCtD
Mefenamic acid—Anorexia—Methotrexate—systemic lupus erythematosus	4.26e-05	0.000419	CcSEcCtD
Mefenamic acid—Rash—Methylprednisolone—systemic lupus erythematosus	4.26e-05	0.000419	CcSEcCtD
Mefenamic acid—Dermatitis—Methylprednisolone—systemic lupus erythematosus	4.25e-05	0.000418	CcSEcCtD
Mefenamic acid—Urticaria—Prednisone—systemic lupus erythematosus	4.25e-05	0.000418	CcSEcCtD
Mefenamic acid—Headache—Triamcinolone—systemic lupus erythematosus	4.24e-05	0.000417	CcSEcCtD
Mefenamic acid—Headache—Methylprednisolone—systemic lupus erythematosus	4.23e-05	0.000416	CcSEcCtD
Mefenamic acid—Abdominal pain—Prednisone—systemic lupus erythematosus	4.23e-05	0.000416	CcSEcCtD
Mefenamic acid—Body temperature increased—Prednisone—systemic lupus erythematosus	4.23e-05	0.000416	CcSEcCtD
Mefenamic acid—Diarrhoea—Dexamethasone—systemic lupus erythematosus	4.2e-05	0.000413	CcSEcCtD
Mefenamic acid—Diarrhoea—Betamethasone—systemic lupus erythematosus	4.2e-05	0.000413	CcSEcCtD
Mefenamic acid—Hypotension—Methotrexate—systemic lupus erythematosus	4.18e-05	0.000411	CcSEcCtD
Mefenamic acid—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—systemic lupus erythematosus	4.17e-05	0.00176	CbGpPWpGaD
Mefenamic acid—AKR1C2—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	4.15e-05	0.00175	CbGpPWpGaD
Mefenamic acid—PTGS1—Selenium Micronutrient Network—IFNG—systemic lupus erythematosus	4.14e-05	0.00175	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—GADD45A—systemic lupus erythematosus	4.13e-05	0.00174	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	4.12e-05	0.00174	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—TLR9—systemic lupus erythematosus	4.07e-05	0.00172	CbGpPWpGaD
Mefenamic acid—Dizziness—Betamethasone—systemic lupus erythematosus	4.06e-05	0.000399	CcSEcCtD
Mefenamic acid—Dizziness—Dexamethasone—systemic lupus erythematosus	4.06e-05	0.000399	CcSEcCtD
Mefenamic acid—Insomnia—Methotrexate—systemic lupus erythematosus	4.04e-05	0.000397	CcSEcCtD
Mefenamic acid—CYP2C8—Arachidonic acid metabolism—PTGS2—systemic lupus erythematosus	4.03e-05	0.0017	CbGpPWpGaD
Mefenamic acid—Nausea—Triamcinolone—systemic lupus erythematosus	4.02e-05	0.000395	CcSEcCtD
Mefenamic acid—Paraesthesia—Methotrexate—systemic lupus erythematosus	4.01e-05	0.000394	CcSEcCtD
Mefenamic acid—Nausea—Methylprednisolone—systemic lupus erythematosus	4.01e-05	0.000394	CcSEcCtD
Mefenamic acid—Dyspnoea—Methotrexate—systemic lupus erythematosus	3.98e-05	0.000392	CcSEcCtD
Mefenamic acid—Somnolence—Methotrexate—systemic lupus erythematosus	3.97e-05	0.000391	CcSEcCtD
Mefenamic acid—PTGS1—Selenium Micronutrient Network—PTGS2—systemic lupus erythematosus	3.97e-05	0.00167	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—P2RY12—systemic lupus erythematosus	3.94e-05	0.00166	CbGpPWpGaD
Mefenamic acid—Dyspepsia—Methotrexate—systemic lupus erythematosus	3.93e-05	0.000387	CcSEcCtD
Mefenamic acid—Vomiting—Dexamethasone—systemic lupus erythematosus	3.9e-05	0.000384	CcSEcCtD
Mefenamic acid—Vomiting—Betamethasone—systemic lupus erythematosus	3.9e-05	0.000384	CcSEcCtD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—JUNB—systemic lupus erythematosus	3.89e-05	0.00164	CbGpPWpGaD
Mefenamic acid—Decreased appetite—Methotrexate—systemic lupus erythematosus	3.88e-05	0.000382	CcSEcCtD
Mefenamic acid—Rash—Betamethasone—systemic lupus erythematosus	3.87e-05	0.000381	CcSEcCtD
Mefenamic acid—Rash—Dexamethasone—systemic lupus erythematosus	3.87e-05	0.000381	CcSEcCtD
Mefenamic acid—AKR1C1—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	3.87e-05	0.00163	CbGpPWpGaD
Mefenamic acid—Dermatitis—Betamethasone—systemic lupus erythematosus	3.87e-05	0.00038	CcSEcCtD
Mefenamic acid—Dermatitis—Dexamethasone—systemic lupus erythematosus	3.87e-05	0.00038	CcSEcCtD
Mefenamic acid—PTGS2—Selenium Micronutrient Network—CCL2—systemic lupus erythematosus	3.86e-05	0.00163	CbGpPWpGaD
Mefenamic acid—Gastrointestinal disorder—Methotrexate—systemic lupus erythematosus	3.86e-05	0.000379	CcSEcCtD
Mefenamic acid—Headache—Dexamethasone—systemic lupus erythematosus	3.85e-05	0.000378	CcSEcCtD
Mefenamic acid—Headache—Betamethasone—systemic lupus erythematosus	3.85e-05	0.000378	CcSEcCtD
Mefenamic acid—Asthenia—Prednisone—systemic lupus erythematosus	3.84e-05	0.000377	CcSEcCtD
Mefenamic acid—Pruritus—Prednisone—systemic lupus erythematosus	3.78e-05	0.000372	CcSEcCtD
Mefenamic acid—AKR1C1—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	3.72e-05	0.00157	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—JUNB—systemic lupus erythematosus	3.72e-05	0.00157	CbGpPWpGaD
Mefenamic acid—AKR1C2—Metabolism—RXRA—systemic lupus erythematosus	3.72e-05	0.00157	CbGpPWpGaD
Mefenamic acid—Feeling abnormal—Methotrexate—systemic lupus erythematosus	3.68e-05	0.000362	CcSEcCtD
Mefenamic acid—Diarrhoea—Prednisone—systemic lupus erythematosus	3.66e-05	0.00036	CcSEcCtD
Mefenamic acid—Gastrointestinal pain—Methotrexate—systemic lupus erythematosus	3.65e-05	0.000359	CcSEcCtD
Mefenamic acid—Nausea—Dexamethasone—systemic lupus erythematosus	3.65e-05	0.000359	CcSEcCtD
Mefenamic acid—Nausea—Betamethasone—systemic lupus erythematosus	3.65e-05	0.000359	CcSEcCtD
Mefenamic acid—AKR1C1—Signaling Pathways—CSK—systemic lupus erythematosus	3.63e-05	0.00153	CbGpPWpGaD
Mefenamic acid—PTGS2—Selenium Micronutrient Network—ALB—systemic lupus erythematosus	3.6e-05	0.00152	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—HIST2H2AC—systemic lupus erythematosus	3.58e-05	0.00151	CbGpPWpGaD
Mefenamic acid—PTGS2—Aryl Hydrocarbon Receptor—TNF—systemic lupus erythematosus	3.57e-05	0.00151	CbGpPWpGaD
Mefenamic acid—PTGS2—Spinal Cord Injury—TLR4—systemic lupus erythematosus	3.56e-05	0.0015	CbGpPWpGaD
Mefenamic acid—Urticaria—Methotrexate—systemic lupus erythematosus	3.55e-05	0.000349	CcSEcCtD
Mefenamic acid—Dizziness—Prednisone—systemic lupus erythematosus	3.54e-05	0.000348	CcSEcCtD
Mefenamic acid—Body temperature increased—Methotrexate—systemic lupus erythematosus	3.53e-05	0.000347	CcSEcCtD
Mefenamic acid—Abdominal pain—Methotrexate—systemic lupus erythematosus	3.53e-05	0.000347	CcSEcCtD
Mefenamic acid—AKR1C3—Disease—CSK—systemic lupus erythematosus	3.49e-05	0.00147	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	3.48e-05	0.00147	CbGpPWpGaD
Mefenamic acid—AKR1C2—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	3.45e-05	0.00146	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—PRL—systemic lupus erythematosus	3.43e-05	0.00145	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—RXRA—systemic lupus erythematosus	3.41e-05	0.00144	CbGpPWpGaD
Mefenamic acid—Vomiting—Prednisone—systemic lupus erythematosus	3.4e-05	0.000334	CcSEcCtD
Mefenamic acid—Rash—Prednisone—systemic lupus erythematosus	3.37e-05	0.000331	CcSEcCtD
Mefenamic acid—Dermatitis—Prednisone—systemic lupus erythematosus	3.37e-05	0.000331	CcSEcCtD
Mefenamic acid—Headache—Prednisone—systemic lupus erythematosus	3.35e-05	0.000329	CcSEcCtD
Mefenamic acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—systemic lupus erythematosus	3.34e-05	0.00141	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—NCF2—systemic lupus erythematosus	3.32e-05	0.0014	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—LYN—systemic lupus erythematosus	3.3e-05	0.00139	CbGpPWpGaD
Mefenamic acid—PTGS2—C-MYB transcription factor network—CD4—systemic lupus erythematosus	3.29e-05	0.00139	CbGpPWpGaD
Mefenamic acid—PTGS2—Selenium Micronutrient Network—IFNG—systemic lupus erythematosus	3.29e-05	0.00139	CbGpPWpGaD
Mefenamic acid—CYP2C9—Arachidonic acid metabolism—PTGS2—systemic lupus erythematosus	3.28e-05	0.00138	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—CD247—systemic lupus erythematosus	3.28e-05	0.00138	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—NAT2—systemic lupus erythematosus	3.28e-05	0.00138	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—SH2B3—systemic lupus erythematosus	3.23e-05	0.00136	CbGpPWpGaD
Mefenamic acid—Asthenia—Methotrexate—systemic lupus erythematosus	3.21e-05	0.000315	CcSEcCtD
Mefenamic acid—AKR1C3—Disease—NCF2—systemic lupus erythematosus	3.19e-05	0.00135	CbGpPWpGaD
Mefenamic acid—Nausea—Prednisone—systemic lupus erythematosus	3.18e-05	0.000312	CcSEcCtD
Mefenamic acid—Pruritus—Methotrexate—systemic lupus erythematosus	3.16e-05	0.000311	CcSEcCtD
Mefenamic acid—PTGS2—C-MYB transcription factor network—CDKN1B—systemic lupus erythematosus	3.1e-05	0.00131	CbGpPWpGaD
Mefenamic acid—Diarrhoea—Methotrexate—systemic lupus erythematosus	3.06e-05	0.000301	CcSEcCtD
Mefenamic acid—PTGS2—Spinal Cord Injury—CCL2—systemic lupus erythematosus	3.06e-05	0.00129	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	3.04e-05	0.00128	CbGpPWpGaD
Mefenamic acid—CYP2C8—Biological oxidations—RXRA—systemic lupus erythematosus	3.02e-05	0.00127	CbGpPWpGaD
Mefenamic acid—Dizziness—Methotrexate—systemic lupus erythematosus	2.96e-05	0.000291	CcSEcCtD
Mefenamic acid—PTGS2—C-MYB transcription factor network—CDKN1A—systemic lupus erythematosus	2.86e-05	0.00121	CbGpPWpGaD
Mefenamic acid—Vomiting—Methotrexate—systemic lupus erythematosus	2.84e-05	0.000279	CcSEcCtD
Mefenamic acid—Rash—Methotrexate—systemic lupus erythematosus	2.82e-05	0.000277	CcSEcCtD
Mefenamic acid—Dermatitis—Methotrexate—systemic lupus erythematosus	2.82e-05	0.000277	CcSEcCtD
Mefenamic acid—Headache—Methotrexate—systemic lupus erythematosus	2.8e-05	0.000275	CcSEcCtD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—FASLG—systemic lupus erythematosus	2.79e-05	0.00118	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—JAK1—systemic lupus erythematosus	2.74e-05	0.00116	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—TLR9—systemic lupus erythematosus	2.74e-05	0.00116	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism—RXRA—systemic lupus erythematosus	2.73e-05	0.00115	CbGpPWpGaD
Mefenamic acid—PTGS2—C-MYB transcription factor network—EP300—systemic lupus erythematosus	2.72e-05	0.00115	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—systemic lupus erythematosus	2.69e-05	0.00114	CbGpPWpGaD
Mefenamic acid—PTGS1—Selenium Micronutrient Network—TNF—systemic lupus erythematosus	2.68e-05	0.00113	CbGpPWpGaD
Mefenamic acid—Nausea—Methotrexate—systemic lupus erythematosus	2.65e-05	0.000261	CcSEcCtD
Mefenamic acid—AKR1C3—Signaling Pathways—P2RY12—systemic lupus erythematosus	2.65e-05	0.00112	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—CXCL12—systemic lupus erythematosus	2.65e-05	0.00112	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—JUNB—systemic lupus erythematosus	2.6e-05	0.0011	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	2.6e-05	0.0011	CbGpPWpGaD
Mefenamic acid—PTGS2—Spinal Cord Injury—IFNG—systemic lupus erythematosus	2.6e-05	0.0011	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—CCR5—systemic lupus erythematosus	2.6e-05	0.0011	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	2.53e-05	0.00107	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	2.51e-05	0.00106	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—JUNB—systemic lupus erythematosus	2.5e-05	0.00106	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—RASGRP1—systemic lupus erythematosus	2.47e-05	0.00104	CbGpPWpGaD
Mefenamic acid—CYP2C9—Biological oxidations—RXRA—systemic lupus erythematosus	2.46e-05	0.00104	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—CSK—systemic lupus erythematosus	2.44e-05	0.00103	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—PRL—systemic lupus erythematosus	2.4e-05	0.00101	CbGpPWpGaD
Mefenamic acid—PTGS2—Spinal Cord Injury—CDKN1B—systemic lupus erythematosus	2.36e-05	0.000996	CbGpPWpGaD
Mefenamic acid—AKR1C2—Metabolism—PPARG—systemic lupus erythematosus	2.35e-05	0.000991	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	2.34e-05	0.000988	CbGpPWpGaD
Mefenamic acid—PTGS2—Spinal Cord Injury—IL2—systemic lupus erythematosus	2.31e-05	0.000974	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—PRL—systemic lupus erythematosus	2.31e-05	0.000973	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—NCF2—systemic lupus erythematosus	2.23e-05	0.000942	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—LYN—systemic lupus erythematosus	2.22e-05	0.000936	CbGpPWpGaD
Mefenamic acid—PTGS2—Spinal Cord Injury—MMP9—systemic lupus erythematosus	2.19e-05	0.000922	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—SH2B3—systemic lupus erythematosus	2.18e-05	0.000918	CbGpPWpGaD
Mefenamic acid—PTGS1—Selenium Micronutrient Network—IL6—systemic lupus erythematosus	2.16e-05	0.000912	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—CD80—systemic lupus erythematosus	2.14e-05	0.000901	CbGpPWpGaD
Mefenamic acid—PTGS2—Selenium Micronutrient Network—TNF—systemic lupus erythematosus	2.13e-05	0.000897	CbGpPWpGaD
Mefenamic acid—AKR1C2—Metabolism—ALB—systemic lupus erythematosus	2.11e-05	0.000891	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	2.05e-05	0.000864	CbGpPWpGaD
Mefenamic acid—AKR1C2—Metabolism—NOS3—systemic lupus erythematosus	2.02e-05	0.000852	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—JAK1—systemic lupus erythematosus	1.92e-05	0.00081	CbGpPWpGaD
Mefenamic acid—AKR1C2—Metabolism—PTGS2—systemic lupus erythematosus	1.85e-05	0.000779	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—JAK1—systemic lupus erythematosus	1.84e-05	0.000778	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—RXRA—systemic lupus erythematosus	1.84e-05	0.000775	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—CCR5—systemic lupus erythematosus	1.82e-05	0.000767	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—TYK2—systemic lupus erythematosus	1.8e-05	0.000761	CbGpPWpGaD
Mefenamic acid—PTGS2—Spinal Cord Injury—TGFB1—systemic lupus erythematosus	1.8e-05	0.00076	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	1.79e-05	0.000757	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—IL2RA—systemic lupus erythematosus	1.79e-05	0.000756	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—CXCL12—systemic lupus erythematosus	1.78e-05	0.000753	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—C3—systemic lupus erythematosus	1.78e-05	0.00075	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—NOS3—systemic lupus erythematosus	1.77e-05	0.000747	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—JUNB—systemic lupus erythematosus	1.75e-05	0.000739	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—CCR5—systemic lupus erythematosus	1.75e-05	0.000737	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism—PPARG—systemic lupus erythematosus	1.72e-05	0.000727	CbGpPWpGaD
Mefenamic acid—PTGS2—Selenium Micronutrient Network—IL6—systemic lupus erythematosus	1.72e-05	0.000724	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	1.7e-05	0.000719	CbGpPWpGaD
Mefenamic acid—PTGS2—Spinal Cord Injury—TNF—systemic lupus erythematosus	1.68e-05	0.00071	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—XRCC6—systemic lupus erythematosus	1.68e-05	0.000708	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—RASGRP1—systemic lupus erythematosus	1.66e-05	0.000702	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—CD4—systemic lupus erythematosus	1.63e-05	0.000688	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—PTGS2—systemic lupus erythematosus	1.62e-05	0.000683	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—PRL—systemic lupus erythematosus	1.61e-05	0.000681	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—systemic lupus erythematosus	1.61e-05	0.000677	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—F2—systemic lupus erythematosus	1.56e-05	0.000658	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism—ALB—systemic lupus erythematosus	1.55e-05	0.000654	CbGpPWpGaD
Mefenamic acid—AKR1C2—Metabolism—EP300—systemic lupus erythematosus	1.54e-05	0.000648	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—CDKN1B—systemic lupus erythematosus	1.53e-05	0.000647	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—CD80—systemic lupus erythematosus	1.5e-05	0.000631	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism—NOS3—systemic lupus erythematosus	1.48e-05	0.000625	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—systemic lupus erythematosus	1.48e-05	0.000625	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—CD80—systemic lupus erythematosus	1.44e-05	0.000606	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—NAT2—systemic lupus erythematosus	1.43e-05	0.000602	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	1.42e-05	0.000601	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—CDKN1A—systemic lupus erythematosus	1.41e-05	0.000597	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—systemic lupus erythematosus	1.41e-05	0.000595	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—CCL2—systemic lupus erythematosus	1.39e-05	0.000587	CbGpPWpGaD
Mefenamic acid—PTGS2—Spinal Cord Injury—IL6—systemic lupus erythematosus	1.36e-05	0.000573	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism—PTGS2—systemic lupus erythematosus	1.36e-05	0.000572	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—EP300—systemic lupus erythematosus	1.35e-05	0.000568	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—systemic lupus erythematosus	1.33e-05	0.000563	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—JAK1—systemic lupus erythematosus	1.29e-05	0.000545	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—TYK2—systemic lupus erythematosus	1.26e-05	0.000533	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—NOS3—systemic lupus erythematosus	1.24e-05	0.000523	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—HIST2H2AC—systemic lupus erythematosus	1.24e-05	0.000522	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—systemic lupus erythematosus	1.23e-05	0.000517	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—CCR5—systemic lupus erythematosus	1.22e-05	0.000516	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—TYK2—systemic lupus erythematosus	1.21e-05	0.000512	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—IL2RA—systemic lupus erythematosus	1.21e-05	0.000509	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—CSK—systemic lupus erythematosus	1.2e-05	0.000508	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—C3—systemic lupus erythematosus	1.2e-05	0.000504	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—NOS3—systemic lupus erythematosus	1.19e-05	0.000502	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—TGFB1—systemic lupus erythematosus	1.17e-05	0.000494	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—PPARG—systemic lupus erythematosus	1.16e-05	0.000489	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	1.16e-05	0.000489	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—systemic lupus erythematosus	1.14e-05	0.000483	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	1.13e-05	0.000478	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—CD247—systemic lupus erythematosus	1.13e-05	0.000478	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—NAT2—systemic lupus erythematosus	1.13e-05	0.000478	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism—EP300—systemic lupus erythematosus	1.13e-05	0.000476	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—NCF2—systemic lupus erythematosus	1.1e-05	0.000465	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—CD4—systemic lupus erythematosus	1.1e-05	0.000463	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—PTGS2—systemic lupus erythematosus	1.09e-05	0.00046	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.07e-05	0.000453	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—IL2—systemic lupus erythematosus	1.05e-05	0.000443	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—F2—systemic lupus erythematosus	1.05e-05	0.000443	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—ALB—systemic lupus erythematosus	1.04e-05	0.00044	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—CDKN1B—systemic lupus erythematosus	1.03e-05	0.000435	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	1.02e-05	0.00043	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—CD80—systemic lupus erythematosus	1.01e-05	0.000425	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—NOS3—systemic lupus erythematosus	9.97e-06	0.000421	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—MMP9—systemic lupus erythematosus	9.94e-06	0.00042	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—CDKN1A—systemic lupus erythematosus	9.91e-06	0.000418	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—CDKN1A—systemic lupus erythematosus	9.52e-06	0.000402	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	9.43e-06	0.000398	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—EP300—systemic lupus erythematosus	9.43e-06	0.000398	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—CCL2—systemic lupus erythematosus	9.36e-06	0.000395	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—NAT2—systemic lupus erythematosus	9.21e-06	0.000389	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—PTGS2—systemic lupus erythematosus	9.12e-06	0.000385	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—EP300—systemic lupus erythematosus	9.06e-06	0.000382	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	9e-06	0.00038	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—VEGFA—systemic lupus erythematosus	8.93e-06	0.000377	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	8.91e-06	0.000376	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—IL6—systemic lupus erythematosus	8.82e-06	0.000372	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—JUNB—systemic lupus erythematosus	8.65e-06	0.000365	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—TYK2—systemic lupus erythematosus	8.49e-06	0.000358	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—NOS3—systemic lupus erythematosus	8.34e-06	0.000352	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—TGFB1—systemic lupus erythematosus	8.19e-06	0.000346	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	8.09e-06	0.000341	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—RXRA—systemic lupus erythematosus	7.99e-06	0.000337	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—PRL—systemic lupus erythematosus	7.97e-06	0.000336	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—TGFB1—systemic lupus erythematosus	7.87e-06	0.000332	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—EP300—systemic lupus erythematosus	7.59e-06	0.00032	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—NAT2—systemic lupus erythematosus	7.5e-06	0.000316	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	7.41e-06	0.000313	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	7.32e-06	0.000309	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—CDKN1B—systemic lupus erythematosus	7.22e-06	0.000305	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—IL2—systemic lupus erythematosus	7.07e-06	0.000298	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—MMP9—systemic lupus erythematosus	6.69e-06	0.000282	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—CDKN1A—systemic lupus erythematosus	6.67e-06	0.000281	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	6.58e-06	0.000278	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—JAK1—systemic lupus erythematosus	6.37e-06	0.000269	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—RXRA—systemic lupus erythematosus	6.34e-06	0.000268	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—EP300—systemic lupus erythematosus	6.34e-06	0.000268	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—IL6—systemic lupus erythematosus	6.17e-06	0.000261	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—CCR5—systemic lupus erythematosus	6.04e-06	0.000255	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—VEGFA—systemic lupus erythematosus	6.01e-06	0.000253	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	5.96e-06	0.000251	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—IL6—systemic lupus erythematosus	5.93e-06	0.00025	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	5.89e-06	0.000248	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	5.76e-06	0.000243	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—TGFB1—systemic lupus erythematosus	5.51e-06	0.000233	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	5.36e-06	0.000226	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—RXRA—systemic lupus erythematosus	5.16e-06	0.000218	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—PPARG—systemic lupus erythematosus	5.05e-06	0.000213	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—CD80—systemic lupus erythematosus	4.97e-06	0.00021	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	4.79e-06	0.000202	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	4.69e-06	0.000198	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—ALB—systemic lupus erythematosus	4.54e-06	0.000191	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—NOS3—systemic lupus erythematosus	4.34e-06	0.000183	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—RXRA—systemic lupus erythematosus	4.2e-06	0.000177	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—TYK2—systemic lupus erythematosus	4.19e-06	0.000177	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—IL6—systemic lupus erythematosus	4.15e-06	0.000175	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—NOS3—systemic lupus erythematosus	4.11e-06	0.000174	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—PPARG—systemic lupus erythematosus	4.01e-06	0.000169	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—PTGS2—systemic lupus erythematosus	3.97e-06	0.000168	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	3.9e-06	0.000164	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—CD4—systemic lupus erythematosus	3.79e-06	0.00016	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—ALB—systemic lupus erythematosus	3.6e-06	0.000152	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—CDKN1B—systemic lupus erythematosus	3.56e-06	0.00015	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—NOS3—systemic lupus erythematosus	3.45e-06	0.000145	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—EP300—systemic lupus erythematosus	3.3e-06	0.000139	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—CDKN1A—systemic lupus erythematosus	3.29e-06	0.000139	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—PPARG—systemic lupus erythematosus	3.26e-06	0.000138	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—EP300—systemic lupus erythematosus	3.13e-06	0.000132	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—ALB—systemic lupus erythematosus	2.93e-06	0.000124	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—NOS3—systemic lupus erythematosus	2.8e-06	0.000118	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—TGFB1—systemic lupus erythematosus	2.72e-06	0.000115	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—PPARG—systemic lupus erythematosus	2.65e-06	0.000112	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—EP300—systemic lupus erythematosus	2.62e-06	0.000111	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—PTGS2—systemic lupus erythematosus	2.56e-06	0.000108	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—ALB—systemic lupus erythematosus	2.39e-06	0.000101	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—NOS3—systemic lupus erythematosus	2.28e-06	9.63e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—EP300—systemic lupus erythematosus	2.13e-06	9e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—PTGS2—systemic lupus erythematosus	2.09e-06	8.81e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—IL6—systemic lupus erythematosus	2.05e-06	8.65e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—EP300—systemic lupus erythematosus	1.74e-06	7.32e-05	CbGpPWpGaD
